The future of animal-free test technologies is promising, as there is a growing demand for these methods and ongoing developments in technology and science.
Advances in cell culture techniques, microfluidic devices, and computer models are making it possible to create increasingly complex and accurate simulations of human biology, which could eventually replace the need for animal testing in many areas of research and product development.
There is also a growing movement towards the use of “organ-on-a-chip” technologies, which use microfluidic devices to recreate the structure and function of specific organs in the body, allowing researchers to test the effects of drugs and chemicals on them in a more accurate and realistic way.
In addition, regulatory bodies are increasingly recognizing the importance of animal-free test technologies and are implementing policies and regulations that require the use of these methods in certain areas of research and product development.
Overall, the future of animal-free test technologies looks bright, as these methods offer a more ethical, scientifically valid, and cost-effective approach to testing the safety and efficacy of products, drugs, and chemicals. Ongoing developments in technology and science will likely continue to improve the accuracy and complexity of these methods, making them an increasingly viable alternative to animal testing.
iPSCs in Human-Relevant Disease Modelling: From Reprogrammed Cells to Advanced In Vitro Systems
Understanding how human diseases develop requires models that can accurately reflect human biology. Traditional cell lines and animal models have played an important role in biomedical research, but they cannot always reproduce the complexity or patient-specific characteristics of human disease. Induced pluripotent stem cells (iPSCs) offer a different approach. By
